Oxoid Agglutinating Sera recalled over Salmonella risk
- Recall date
- March 25, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Remel Europe Ltd. recalls Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
- Recall number
- Z-1923-2026
- FDA classification
- Class II
- Brand / firm
- Remel Europe Ltd.
- Sold / distributed
- Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
Why it was recalled
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Get recall alerts
Free email alert whenever Remel Europe Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Remel Europe Ltd.